Hemopericardium with cardiac tamponade in chronic uremia.

W. Guild,G. Bray,J. Merrill

DOI: https://doi.org/10.1056/NEJM195708012570509

IF: 158.5

1957-08-01

New England Journal of Medicine

Abstract:DURING the past thirty years the number of diverse clinical manifestations of chronic uremia appearing in the medical literature has steadily increased. Important among these is a hemorrhagic tende...

What problem does this paper attempt to address?

Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis

Chaoyi Xia,Xiyue Xing,Wenxia Zhang,Yang Wang,Xin Jin,Yang Wang,Meihong Tian,Xueqing Ba,Fengqi Hao

DOI: https://doi.org/10.1016/j.redox.2023.102999

IF: 11.4

2023-12-23

Redox Biology

Abstract:Ferroptosis is inhibited by glutathione peroxidase 4 (GPX4), an antioxidant enzyme that uses reduced glutathione (GSH) as a cofactor to detoxify lipid hydroperoxides. As a selenoprotein, the core function of GPX4 is the thiol-dependent redox reaction. In addition to GSH, other small molecules such as cysteine and homocysteine also contain thiols; yet, whether GPX4 can exploit cysteine and homocysteine to directly detoxify lipid hydroperoxides and inhibit ferroptosis has not been addressed. In this study, we found that cysteine and homocysteine inhibit ferroptosis in a GPX4-dependent manner. However, cysteine inhibits ferroptosis independent of GSH synthesis, and homocysteine inhibits ferroptosis through non-cysteine and non-GSH pathway. Furthermore, we used molecular docking and GPX4 activity analysis to study the binding patterns and affinity between GPX4 and GSH, cysteine, and homocysteine. We found that besides GSH, cysteine and homocysteine are also able to serve as substrates for GPX4 though the affinities of GPX4 with cysteine and homocysteine are lower than that with GSH. Importantly, GPX family and the GSH synthetase pathway might be asynchronously evolved. When GSH synthetase is absent, for example in Flexibacter , the fGPX exhibits higher affinity with cysteine and homocysteine than GSH. Taken together, the present study provided the understanding of the role of thiol-dependent redox systems in protecting cells from ferroptosis and propose that GSH might be a substitute for cysteine or homocysteine to be used as a cofactor for GPX4 during the evolution of aerobic metabolism.

biochemistry & molecular biology
A potent GPX4 degrader to induce ferroptosis in HT1080 cells

Haoze Song,Jing Liang,Yuanyuan Guo,Yang Liu,Kuiru Sa,Guohong Yan,Wen Xu,Wei Xu,Lixia Chen,Hua Li

DOI: https://doi.org/10.1016/j.ejmech.2023.116110

IF: 7.088

2024-01-10

European Journal of Medicinal Chemistry

Abstract:Glutathione peroxidase 4 (GPX4) is the most promising target for inducing ferroptosis. GPX4-targeting strategies primarily focus on inhibiting its activity or adjusting its cellular level. However, small inhibitors have limitations due to the covalent reactive alkyl chloride moiety, which could lead to poor selectivity and suboptimal pharmacokinetic properties. Herein, we designed and synthesized a series of proteolysis targeting chimeras (PROTACs) by connecting RSL3, a small molecule inhibitor of GPX4, with six different ubiquitin ligase ligands. As a highly effective degrader, compound 18a is a potent degrader (DC 50, 48h = 1.68 μM, D max, 48h = 85 %). It also showed an obvious anti-proliferative effect with the IC 50 value of 2.37 ± 0.17 μM in HT1080. Mechanism research showed that compound 18a formed a ternary complex with GPX4 and cIAP and induced the degradation of GPX4 through the ubiquitin-proteasome system pathway. Furthermore, compound 18a also induced the accumulation of lipid peroxides and mitochondrial depolarization, subsequently triggering ferroptosis. Our work demonstrated the practicality and efficiency of the PROTAC strategy and offered a promising avenue for designing degraders to induce ferroptosis in cancer cells.

chemistry, medicinal
Protein S-glutathionylation confers cell resistance to ferroptosis

Yi Ju,Yuting Zhang,Yiming Qiao,Xiaolin Tian,Yufan Zheng,Tao Yang,Baolin Niu,Xiaoyun Li,Liu Yu,Zhuolin Liu,Yixuan Wu,Yang Zhi,Yinuo Dong,Qingling Xu,Xuening Wang,Xiaokai Wang,Yimin Mao,Xiaobo Li

DOI: https://doi.org/10.1101/2024.05.03.592374

2024-05-05

Abstract:Ferroptosis is a type of cell death that is strongly associated with the cellular redox state. Glutathione is the key to buffering lipid peroxidation in ferroptosis and can also modify proteins by S-glutathionylation under oxidative stress. Here, we showed that the strong associations among glutathione pools, protein S-glutathionylation, and susceptibility to ferroptosis existed broadly in ferroptosis induced by erastin or acetaminophen. Deficiency of CHAC1, a glutathione-degrading enzyme, led to decreased glutathione pools and reduced protein S-glutathionylation, improved liver function and attenuated hepatocyte ferroptosis upon acetaminophen challenge, which could be retarded by CHAC1 overexpression. We conducted quantitative redox proteomics in primary mouse hepatocytes to identify glutathione pool-sensitive S-glutathionylated proteins and found that S-glutathionylation is required to maintain the function of ADP-ribosylation factor 6 (ARF6). Our data suggest that aberrant ARF6 S-glutathionylation increases the labile iron pool by delaying the recycling of transferrin receptors, thereby promoting ferroptosis. Our study reveals the importance of protein S-glutathionylation in conferring cell resistance to ferroptosis.

Cell Biology
System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

Feng-Jiao Li,Hui-Zhi Long,Zi-Wei Zhou,Hong-Yu Luo,Shuo-Guo Xu,Li-Chen Gao

DOI: https://doi.org/10.3389/fphar.2022.910292

IF: 5.6

2022-08-29

Frontiers in Pharmacology

Abstract:The activation of ferroptosis is a new effective way to treat drug-resistant solid tumors. Ferroptosis is an iron-mediated form of cell death caused by the accumulation of lipid peroxides. The intracellular imbalance between oxidant and antioxidant due to the abnormal expression of multiple redox active enzymes will promote the produce of reactive oxygen species (ROS). So far, a few pathways and regulators have been discovered to regulate ferroptosis. In particular, the cystine/glutamate antiporter (System X c − ), glutathione peroxidase 4 (GPX4) and glutathione (GSH) (System X c − /GSH/GPX4 axis) plays a key role in preventing lipid peroxidation-mediated ferroptosis, because of which could be inhibited by blocking System X c − /GSH/GPX4 axis. This review aims to present the current understanding of the mechanism of ferroptosis based on the System X c − /GSH/GPX4 axis in the treatment of drug-resistant solid tumors.

pharmacology & pharmacy
An Overview of High Order Reverse Mode

Mu Wang,A. Pothen

2017-10-28

Abstract:Automatic Differentiation (AD) is increasingly an important component of Machine Learning (ML) packages. For evaluating the gradient, the first order reverse mode also known as back-propagation, is optimal and is widely used. However, the functionalities of current mainstream ML packages for evaluating second and higher order derivatives are limited. One reason is that high order derivatives are computed using an overlay of first order forward and reverse modes. Here we describe an algorithm and code that directly implements the high order reverse mode, called ReverseAD. It is more efficient than previous methods, especially when evaluating sparse derivatives. 1 High Order Reverse Mode of Automatic Differentiation
Is Loop Drainage Technique More Effective for Treatment of Soft Tissue Abscess Compared With Conventional Incision and Drainage?

B. Long,M. April

DOI: https://doi.org/10.1016/j.annemergmed.2018.02.006

IF: 6.762

2019-01-01

Annals of Emergency Medicine

Abstract:
Respiratory symptoms and pathophysiological effects of occupational exposure to formaldehyde and wood dust.

M. Holmström,B. Wilhelmsson

DOI: https://doi.org/10.5271/SJWEH.1915

1988-10-01

Scandinavian Journal of Work, Environment and Health

Abstract:The hazards of exposure to formaldehyde have been widely discussed in recent years on account of the health complaints of exposed persons. Both domestic and occupational exposure to formaldehyde is common. In the present study the effects of formaldehyde alone and in combination with wood dust, another nasal irritant, on the upper and lower respiratory tract have been investigated. The effects were correlated with the duration and degree of exposure. Discomfort from both the upper and lower airways was more frequent in the exposed group than in the unexposed group. Nasal obstruction among the exposed subjects in general could not be detected by rhinomanometric measurements, but, for the group exposed to formaldehyde alone and with a history of nasal blocking, there was significant nasal mucosal swelling. The nasal mucociliary clearance was significantly delayed, and the sense of smell was significantly reduced in the exposed groups when they were compared with the referents. Spirometry showed a significantly decreased forced vital capacity in the exposed groups. There were no signs in this investigation that duration of exposure or level of exposure to formaldehyde would have any influence on the severity of symptoms or the impairment of physiological conditions.
GPX4, ferroptosis, and diseases

Wangzheqi Zhang,Yang Liu,Yan Liao,Chenglong Zhu,Zui Zou

DOI: https://doi.org/10.1016/j.biopha.2024.116512

IF: 7.419

2024-04-05

Biomedicine & Pharmacotherapy

Abstract:GPX4 (Glutathione peroxidase 4) serves as a crucial intracellular regulatory factor, participating in various physiological processes and playing a significant role in maintaining the redox homeostasis within the body. Ferroptosis, a form of iron-dependent non-apoptotic cell death, has gained considerable attention in recent years due to its involvement in multiple pathological processes. GPX4 is closely associated with ferroptosis and functions as the primary inhibitor of this process. Together, GPX4 and ferroptosis contribute to the pathophysiology of several diseases, including sepsis, nervous system diseases, ischemia reperfusion injury, cardiovascular diseases, and cancer. This review comprehensively explores the regulatory roles and impacts of GPX4 and ferroptosis in the development and progression of these diseases, with the aim of providing insights for identifying potential therapeutic strategies in the future.

pharmacology & pharmacy,medicine, research & experimental
ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells

Mengdie Hu,Xiaomei Li,Lin Wang,Yanping Zhang,Yujie Sun,Hui Hua,Huina Liu,Ting Cai,Dongsheng Zhu,Qiuping Xiang

DOI: https://doi.org/10.1021/acsmedchemlett.3c00571

2024-02-15

ACS Medicinal Chemistry Letters

Abstract:Ferroptosis is a novel form of oxidative cell death triggered by iron-dependent lipid peroxidation. The induction of ferroptosis presents an attractive therapeutic strategy for human diseases, such as prostate cancer and breast cancer. Herein, we describe our design, synthesis, and biological evaluation of endogenous glutathione peroxidase 4 (GPX4) degraders using the proteolysis targeting chimera (PROTAC) approach with the aim of inducing ferroptosis in cancer cells. Our efforts led to the discovery of compound 5i (ZX703), which significantly degraded GPX4 through the ubiquitin–proteasome and the autophagy–lysosome pathways in a dose- and time-dependent manner. Moreover, 5i was found to induce the accumulation of lipid reactive oxygen species (ROS) in HT1080 cells, thereby inducing ferroptosis. This study provides an attractive intervention strategy for ferroptosis-related diseases.

chemistry, medicinal
The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1

Dorian M. Cheff,Chuying Huang,Karoline C. Scholzen,Radosveta Gencheva,Michael H. Ronzetti,Qing Cheng,Matthew D. Hall,Elias S.J. Arnér

DOI: https://doi.org/10.1016/j.redox.2023.102703

IF: 11.4

2023-04-19

Redox Biology

Abstract:Ferroptosis is defined as cell death triggered by iron-dependent lipid peroxidation that is preventable by antioxidant compounds such as ferrostatin-1. Endogenous suppressors of ferroptosis include FSP-1 and the selenoprotein GPX4, the latter of which directly enzymatically reduces lipid hydroperoxides. Small molecules that trigger ferroptosis include RSL3, ML162, and ML210; these compounds are often used in studies of ferroptosis and are generally considered as GPX4 inhibitors. Here, we found that RSL3 and ML162 completely lack capacity of inhibiting the enzymatic activity of recombinant selenoprotein GPX4. Surprisingly, these compounds were instead found to be efficient inhibitors of another selenoprotein, TXNRD1. Other known inhibitors of TXNRD1, including auranofin, TRi-1 and TRi-2, are also efficient inducers of cell death but that cell death could not be suppressed with ferrostatin-1. Our results collectively suggest that prior studies using RSL3 and ML162 may need to be reevaluated in the context of ferroptosis with regards to additional enzyme targets and mechanisms of action that may be involved.

biochemistry & molecular biology
GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes

Huanjuan Li,Yanchun Li,Yanhua Yu,Xueying Ren,Chen Yang,Weidong Jin,Keyi Li,Yi Zhou,Cuiyun Wu,Yuhuan Shen,Wanye Hu,Yingchao Liu,Lingyan Yu,Xiangmin Tong,Jing Du,Ying Wang

DOI: https://doi.org/10.1016/j.freeradbiomed.2024.06.006

Abstract:The clinical application of the therapeutic approach in myelodysplastic syndromes (MDS) remains an insurmountable challenge for the high propensity for progressing to acute myeloid leukemia and predominantly affecting elderly individuals. Thus, the discovery of molecular mechanisms underlying the regulatory network of different programmed cell death holds great promise for the identification of therapeutic targets and provides insights into new therapeutic avenues. Herein, we found that disulfiram/copper (DSF/Cu) significantly repressed the cell viability, increased reactive oxygen species (ROS) accumulation, destroyed mitochondrial morphology, and altered oxygen consumption rate. Further studies verified that DSF/Cu induces cuproptosis, as evidenced by the depletion of glutathione (GSH), aggregation of lipoylated DLAT, and induced loss of Fe-S cluster-containing proteins, which could be rescued by tetrathiomolybdate and knockdown of ferredoxin 1 (FDX1). Additionally, GSH contributed to the tolerance of DSF/Cu-mediated cuproptosis, while pharmacological chelation of GSH triggered ROS accumulation and sensitized cell death. The xCT-GSH-GPX4 axis is the ideal downstream component of ferroptosis that exerts a powerful protective mechanism. Notably, classical xCT inhibitors were capable of leading to the catastrophic accumulation of ROS and exerting synergistic cell death, while xCT overexpression restored these phenomena. Simvastatin, an inhibitor of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase, has beneficial effects in repurposing for inhibiting GPX4. Similarly, the combination treatment of DSF/Cu and simvastatin dramatically decreased the expression of GPX4 and Fe-S proteins, ultimately accelerating cell death. Moreover, we identified that the combination treatment of DSF/Cu and simvastatin also had a synergistic antitumor effect in the MDS mouse model, with the reduced GPX4, increased COX-2 and accumulated lipid peroxides. Overall, our study provided insight into developing a novel synergistic strategy to sensitize MDS therapy by targeting ferroptosis and cuproptosis.
Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases

Can Cui,Fei Yang,Qian Li

DOI: https://doi.org/10.3389/fmolb.2022.901565

IF: 6.113

2022-05-13

Frontiers in Molecular Biosciences

Abstract:Glutathione peroxidase 4 (GPX4) is one of the most important antioxidant enzymes. As the key regulator of ferroptosis, GPX4 has attracted considerable attention in the fields of cancer, cardiovascular, and neuroscience research in the past 10 years. How to regulate GPX4 activity has become a hot topic nowadays. GPX4 protein level is regulated transcriptionally by transcription factor SP2 or Nrf2. GPX4 activity can be upregulated by supplementing intracellular selenium or glutathione, and also be inhibited by ferroptosis inducers such as ML162 and RSL3. These regulatory mechanisms of GPX4 level/activity have already shown a great potential for treating ferroptosis-related diseases in preclinical studies, especially in cancer cells. Until recently, research show that GPX4 can undergo post-translational modifications (PTMs), such as ubiquitination, succination, phosphorylation, and glycosylation. PTMs of GPX4 affect the protein level/activity of GPX4, indicating that modifying these processes can be a potential therapy for treating ferroptosis-related diseases. This article summarizes the protein characteristics, enzyme properties, and PTMs of GPX4. It also provides a hypothetical idea for treating ferroptosis-related diseases by targeting the PTMs of GPX4.

biochemistry & molecular biology
Regulation of Ferroptotic Cancer Cell Death by GPX4

Wan Seok Yang,Rohitha SriRamaratnam,Matthew E. Welsch,Kenichi Shimada,Rachid Skouta,Vasanthi S. Viswanathan,Jaime H. Cheah,Paul A. Clemons,Alykhan F. Shamji,Clary B. Clish,Lewis M. Brown,Albert W. Girotti,Virginia W. Cornish,Stuart L. Schreiber,Brent R. Stockwell,Wan Seok Yang,Matthew E. Welsch,Vasanthi S. Viswanathan,Jaime H. Cheah,Paul A. Clemons,Alykhan F. Shamji,Clary B. Clish,Lewis M. Brown,Albert W. Girotti,Virginia W. Cornish,Stuart L. Schreiber,Brent R. Stockwell

DOI: https://doi.org/10.1016/j.cell.2013.12.010

IF: 64.5

2014-01-01

Cell

Abstract:Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosis-inducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.

cell biology,biochemistry & molecular biology
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

Solveigh C. Koeberle,Anna P. Kipp,Hermann Stuppner,Andreas Koeberle

DOI: https://doi.org/10.1002/med.21933

2023-01-20

Medicinal Research Reviews

Abstract:Ferroptosis is an iron‐dependent cell death program that is characterized by excessive lipid peroxidation. Triggering ferroptosis has been proposed as a promising strategy to fight cancer and overcome drug resistance in antitumor therapy. Understanding the molecular interactions and structural features of ferroptosis‐inducing compounds might therefore open the door to efficient pharmacological strategies against aggressive, metastatic, and therapy‐resistant cancer. We here summarize the molecular mechanisms and structural requirements of ferroptosis‐inducing small molecules that target central players in ferroptosis. Focus is placed on (i) glutathione peroxidase (GPX) 4, the only GPX isoenzyme that detoxifies complex membrane‐bound lipid hydroperoxides, (ii) the cystine/glutamate antiporter system Xc− that is central for glutathione regeneration, (iii) the redox‐protective transcription factor nuclear factor erythroid 2‐related factor (NRF2), and (iv) GPX4 repression in combination with induced heme degradation via heme oxygenase‐1. We deduce common features for efficient ferroptotic activity and highlight challenges in drug development. Moreover, we critically discuss the potential of natural products as ferroptosis‐inducing lead structures and provide a comprehensive overview of structurally diverse biogenic and bioinspired small molecules that trigger ferroptosis via iron oxidation, inhibition of the thioredoxin/thioredoxin reductase system or less defined modes of action.

pharmacology & pharmacy,chemistry, medicinal
Evaluation of Methodology PBL Done by Students

B. Amante,A. Lacayo,M. Piqué,S. Oliver,P. Ponsa,R. Vilanova

DOI: https://doi.org/10.1109/TEE.2010.5508811

2010-04-06

Abstract:This article presents the application of PBL (Project Based Learning) methodology in a subject called Projects within the degree of Industrial Organization (ETSEIATUPC) and includes a detailed feedback from students in terms of their "experiences and feelings" about such implementation. It is, therefore, a real project carried out by students in which they themselves assume responsibilities and, hence, perform an active role in their own learning process always following the guidelines set by the professor, who designs specific activities or recreates scenarios accordingly. Thereby, in the present article we explain how a group of students assess PBL methodology in their tuition and practice and, especially, when carrying out and finishing a set project. Our contribution, then, goes a step further than usual as it deals with more than just filling up questionnaires and gathering opinions but it incorporates students' views on the methodological tools used both in the theoretical and practical sessions which offers us, professors, a very useful inside information of students' perceptions an views while using PBL for their Engineering project.
Understanding the unique mechanism of ferroptosis: a promising therapeutic target

Yuanyuan Kong,Jing Li,Rufeng Lin,Shifeng Lu,Liucheng Rong,Yao Xue,Yongjun Fang

DOI: https://doi.org/10.3389/fcell.2023.1329147

IF: 5.5

2024-03-18

Frontiers in Cell and Developmental Biology

Abstract:Ferroptosis is an iron-dependent form of regulated cell death and is characterized by high concentrations of intracellular lipid peroxide and a redox imbalance in the cells. Ferroptosis shows distinct morphological and biological features compared with other prominent mechanisms of programmed cell death. The distinct characteristics of ferroptosis include the dysfunction of the lipid peroxide repair enzyme glutathione peroxidase 4, the presence of ferrous iron overload, and the lipid peroxidation of polyunsaturated fatty acids. Several other metabolic pathways (including iron, lipid, and amino acid metabolism) and ferritinophagy, as well as transcription factors, can modulate ferroptosis. However, to date, the molecular mechanism of ferroptosis has not been elucidated. This review outlines the discovery, characterization, regulatory mechanisms, and crosstalk of ferroptosis. Further, we have noted the controversial elements in the ferroptosis-related mechanisms. Our inferences may provide a partial reference for developing strategies to regulate ferroptosis.

cell biology,developmental biology
Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis

Ping Zhang,Chaoting Zhou,Xueying Ren,Qiangan Jing,Yan Gao,Chen Yang,Yuhuan Shen,Yi Zhou,Wanye Hu,Feifan Jin,Haifeng Xu,Lingyan Yu,Yingchao Liu,Xiangmin Tong,Yanchun Li,Ying Wang,Jing Du

DOI: https://doi.org/10.1016/j.redox.2023.103007

IF: 11.4

2023-12-21

Redox Biology

Abstract:Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors and the fourth leading cause of cancer-related death globally, which is characterized by complicated pathophysiology, high recurrence rate, and poor prognosis. Our previous study has demonstrated that Disulfiram (DSF)/Cu could be repurposed for the treatment of HCC by inducing ferroptosis. However, the effectiveness of DSF/Cu may be compromised by compensatory mechanisms that weaken its sensitivity. The mechanisms underlying these compensatory responses are currently unknown. Herein, we found DSF/Cu induces endoplasmic reticulum stress with disrupted ER structures, increased Ca 2+ level and activated expression of ATF4. Further studies verified that DSF/Cu induces both ferroptosis and cuproptosis, accompanied by the depletion of GSH, elevation of lipid peroxides, and compensatory increase of xCT. Comparing ferroptosis and cuproptosis, it is interesting to note that GSH acts at the crossing point of the regulation network and therefore, we hypothesized that compensatory elevation of xCT may be a key aspect of the therapeutic target. Mechanically, knockdown of ATF4 facilitated the DSF/Cu-induced cell death and exacerbated the generation of lipid peroxides under the challenge of DSF/Cu. However, ATF4 knockdown was unable to block the compensatory elevation of xCT and the GSH reduction. Notably, we found that DSF/Cu induced the accumulation of ubiquitinated proteins, promoted the half-life of xCT protein, and dramatically dampened the ubiquitination–proteasome mediated degradation of xCT. Moreover, both pharmacologically and genetically suppressing xCT exacerbated DSF/Cu-induced cell death. In conclusion, the current work provides an in-depth study of the mechanism of DSF/Cu-induced cell death and describes a framework for the further understanding of the crosstalk between ferroptosis and cuproptosis. Inhibiting the compensatory increase of xCT renders HCC cells more susceptible to DSF/Cu, which may provide a promising synergistic strategy to sensitize tumor therapy and overcome drug resistance, as it activates different programmed cell death.

biochemistry & molecular biology
A tangible method to assess native ferroptosis suppressor activity

Toshitaka Nakamura,Junya Ito,André Santos Dias Mourão,Adam Wahida,Kiyotaka Nakagawa,Eikan Mishima,Marcus Conrad

DOI: https://doi.org/10.1016/j.crmeth.2024.100710

2024-03-25

Abstract:Ferroptosis, a regulated cell death hallmarked by unrestrained lipid peroxidation, plays a pivotal role in the pathophysiology of various diseases, making it a promising therapeutic target. Glutathione peroxidase 4 (GPX4) prevents ferroptosis by reducing (phospho)lipid hydroperoxides, yet evaluation of its actual activity has remained arduous. Here, we present a tangible method using affinity-purified GPX4 to capture a snapshot of its native activity. Next to measuring GPX4 activity, this improved method allows for the investigation of mutational GPX4 activity, exemplified by the GPX4U46C mutant lacking selenocysteine at its active site, as well as the evaluation of GPX4 inhibitors, such as RSL3, as a showcase. Furthermore, we apply this method to the second ferroptosis guardian, ferroptosis suppressor protein 1, to validate the newly identified ferroptosis inhibitor WIN62577. Together, these methods open up opportunities for evaluating alternative ferroptosis suppression mechanisms.
On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death

Omkar Zilka,Ron Shah,Bo Li,José Pedro Friedmann Angeli,Markus Griesser,Marcus Conrad,Derek A. Pratt,José Pedro Friedmann Angeli

DOI: https://doi.org/10.1021/acscentsci.7b00028

IF: 18.2

2017-03-07

ACS Central Science

Abstract:Ferroptosis is a form of regulated necrosis associated with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidation has been implicated. High-throughput screening efforts have identified ferrostatin-1 (Fer-1) and liproxstatin-1 (Lip-1) as potent inhibitors of ferroptosis - an activity that has been ascribed to their ability to slow the accumulation of lipid hydroperoxides. Herein we demonstrate that this activity likely derives from their reactivity as radical-trapping antioxidants (RTAs) rather than their potency as inhibitors of lipoxygenases. Although inhibited autoxidations of styrene revealed that Fer-1 and Lip-1 react roughly 10-fold more slowly with peroxyl radicals than reactions of α-tocopherol (α-TOH), they were significantly more reactive than α-TOH in phosphatidylcholine lipid bilayers - consistent with the greater potency of Fer-1 and Lip-1 relative to α-TOH as inhibitors of ferroptosis. None of Fer-1, Lip-1, and α-TOH inhibited human 15-lipoxygenase-1 (15-LOX-1) overexpressed in HEK-293 cells when assayed at concentrations where they inhibited ferroptosis. These results stand in stark contrast to those obtained with a known 15-LOX-1 inhibitor (PD146176), which was able to inhibit the enzyme at concentrations where it was effective in inhibiting ferroptosis. Given the likelihood that Fer-1 and Lip-1 subvert ferroptosis by inhibiting lipid peroxidation as RTAs, we evaluated the antiferroptotic potential of 1,8-tetrahydronaphthyridinols (hereafter THNs): rationally designed radical-trapping antioxidants of unparalleled reactivity. We show for the first time that the inherent reactivity of the THNs translates to cell culture, where lipophilic THNs were similarly effective to Fer-1 and Lip-1 at subverting ferroptosis induced by either pharmacological or genetic inhibition of the hydroperoxide-detoxifying enzyme Gpx4 in mouse fibroblasts, and glutamate-induced death of mouse hippocampal cells. These results demonstrate that potent RTAs subvert ferroptosis and suggest that lipid peroxidation (autoxidation) may play a central role in the process.

chemistry, multidisciplinary
Ferroptosis: A Novel Anti-tumor Action for Cisplatin

Jipeng Guo,Bingfei Xu,Qi Han,Hongxia Zhou,Yun Xia,Chongwen Gong,Xiaofang Dai,Zhenyu Li,Gang Wu

DOI: https://doi.org/10.4143/crt.2016.572

IF: 5.036

2018-04-15

Cancer Research and Treatment

Abstract:PURPOSE: Ferroptosis is a new mode of regulated cell death, which is completely distinct from other cell death modes based on morphological, biochemical, and genetic criteria. This study evaluated the therapeutic role of ferroptosis in classic chemotherapy drugs, including the underlying mechanism.MATERIALS AND METHODS: Cell viabilitywas detected by using the methylthiazoltetrazlium dye uptake method. RNAiwas used to knockout iron-responsive element binding protein 2, and polymerase chain reaction, western blot was used to evaluate the efficiency. Intracellular reduced glutathione level and glutathione peroxidases activitywere determined by related assay kit. Intracellularreactive oxygen species levelswere determined by flowcytometry. Electron microscopywas used to observe ultrastructure changes in cell.RESULTS: Among five chemotherapeutic drugs screened in this study, cisplatin was found to be an inducer for both ferroptosis and apoptosis in A549 and HCT116 cells. The depletion of reduced glutathione caused by cisplatin and the inactivation of glutathione peroxidase played the vital role in the underlying mechanism. Besides, combination therapy of cisplatin and erastin showed significant synergistic effect on their anti-tumor activity.CONCLUSION: Ferroptosis had great potential to become a new approach in anti-tumor therapies and make up for some classic drugs, which open up a new way for their utility in clinic.

oncology

Hemopericardium with cardiac tamponade in chronic uremia.

Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis

A potent GPX4 degrader to induce ferroptosis in HT1080 cells

Protein S-glutathionylation confers cell resistance to ferroptosis

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

An Overview of High Order Reverse Mode

Is Loop Drainage Technique More Effective for Treatment of Soft Tissue Abscess Compared With Conventional Incision and Drainage?

Respiratory symptoms and pathophysiological effects of occupational exposure to formaldehyde and wood dust.

GPX4, ferroptosis, and diseases

ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells

The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1

GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases

Regulation of Ferroptotic Cancer Cell Death by GPX4

Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

Evaluation of Methodology PBL Done by Students

Understanding the unique mechanism of ferroptosis: a promising therapeutic target

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis

A tangible method to assess native ferroptosis suppressor activity

On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death

Ferroptosis: A Novel Anti-tumor Action for Cisplatin